Quintiles

Richard Pilnik has been appointed president of Innovex, a Quintiles company that provides product lifecycle management services to pharmaceutical and biotech companies. Innovex has approximately 7,500 employees in 17 markets, selling and supporting brands in various therapeutic areas in both primary and secondary care.

Mr. Pilnik has 25 years of experience in the pharmaceutical commercial sector, most recently as group vice president and chief marketing officer at Lilly’s Indianapolis headquarters in the U.S. and served in increasing leadership roles in Venezuela, Brazil, Mexico and Europe.

“With Rich’s experience in addressing complex business opportunities and challenges across many countries, together with the experience and expertise we already have, Innovex is poised to expand its visibility and leadership in the commercial arena,” said Quintiles’ chairman and chief executive officer, Dennis Gillings.